help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on February 9, 2006
Molecular Endocrinology, doi:10.1210/me.2005-0518
A more recent version of this article appeared on July 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data Figures
Right arrow All Versions of this Article:
20/7/1623    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNay, D. E.G.
Right arrow Articles by Ang, S.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNay, D. E.G.
Right arrow Articles by Ang, S.-L.

Submitted on December 16, 2005
Accepted on February 2, 2006

Mash1 is required for generic and subtype differentiation of hypothalamic neuroendocrine cells

David E.G. McNay, Michelle Pelling, Suzanne Claxton, François Guillemot, and Siew-Lan Ang*

Division of Developmental Neurobiology and Division of Molecular Neurobiology, MRC The National Institute of Medical Research, Mill Hill, London, NW7 1AA

* To whom correspondence should be addressed. E-mail: sang{at}nimr.mrc.ac.uk.

The neuroendocrine hypothalamus regulates a number of critical biological processes and underlies a range of diseases from growth failure to obesity. While the elucidation of hypothalamic function has progressed well, knowledge of hypothalamic development is poor. In particular little is known about the processes underlying the neurogenesis and specification of neurons of the ventral nuclei, the arcuate and ventromedial nuclei. The proneural gene Mash1 is expressed throughout the basal retrochiasmatic neuroepithelium and loss of Mash1 results in hypoplasia of both the arcuate and ventromedial nuclei. These defects are due to a failure of neurogenesis and apoptosis, a defect that can be rescued by ectopic Ngn2 under the control of the Mash1 promoter. In addition to its role in neurogenesis, analysis of Mash1-/-, Mash1+/-, Mash1KINgn2/KINgn2 and Mash1KINgn2/+ mice demonstrates that Mash1 is specifically required for Gsh1 expression and subsequent GHRH expression, positively regulates SF1 expression and suppresses both TH and NPY expression. While Mash1 is not required for POMC expression, it is required for normal development of POMC+ neurons. These data demonstrate that Mash1 is both required for the generation of ventral neuroendocrine neurons as well as playing a central role in subtype specification of these neurons.


Key words: Hypothalamus • Neurogenesis • Mash1 • Differentiation • Arcuate nucleus




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H.-Y. Chu and A. Ohtoshi
Cloning and Functional Analysis of Hypothalamic Homeobox Gene Bsx1a and Its Isoform, Bsx1b
Mol. Cell. Biol., May 15, 2007; 27(10): 3743 - 3749.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Q. Ma
Transcriptional regulation of neuronal phenotype in mammals
J. Physiol., September 1, 2006; 575(2): 379 - 387.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society